What Is BPC-157?
BPC-157 is a synthetic pentadecapeptide derived from a protein found naturally in gastric juice. The name stands for Body Protection Compound-157. It has been the subject of preclinical research, primarily in animal models, examining its potential role in tissue repair, recovery, and gastrointestinal health.
In clinic directory contexts, BPC-157 is frequently referenced within recovery-oriented, regenerative medicine, and sports performance pathways. Clinics may include it alongside other peptides in protocols targeting injury recovery, joint support, or gut health.
However, it is important to note that BPC-157 does not currently have regulatory approval as a pharmaceutical in the UK or US. It is not approved by the FDA or the MHRA for human use. The existing evidence base is largely preclinical and the quality of available human studies is limited. This does not mean it has no potential, but it does mean that claims about its effects should be evaluated critically.
When evaluating clinics offering BPC-157, ask specifically about the evidence base they are using to justify its inclusion, the regulatory status in your jurisdiction, how it is sourced and compounded, and what monitoring is included in the protocol.
Clinics that reference BPC-157 should be transparent about the exploratory nature of its use and should not make guaranteed outcome claims. A thorough intake assessment and clinician oversight are essential.
This page is informational only and does not constitute a recommendation to pursue BPC-157 therapy. Always consult a licensed clinician before considering any peptide protocol.
Source: MHRA: MHRA Products register · United Kingdom · Status verified August 30, 2026
Source: FDA: Drugs@FDA (openFDA) — no matching approved product · United States · Status verified August 31, 2026
In the US, the position changed on October 28, 2026: an interim HHS policy now lets state-licensed pharmacies compound BPC-157, on its own, for an individual prescription. It is still not FDA approved. Our US guide to BPC-157 prescriptions sets out what changed, what the policy does not cover and what a prescription costs. For the research, side effects, dosing and legal status in one place, see our BPC-157 peptide page.
Frequently asked questions
What is BPC-157?
BPC-157 is a synthetic peptide derived from a protein found in gastric juice. It is frequently referenced in recovery and regenerative medicine clinic contexts.
Is BPC-157 legal?
BPC-157 does not have regulatory approval as a pharmaceutical in the UK, US, or EU. Regulatory status varies by jurisdiction. Always verify with a licensed clinician before pursuing any peptide protocol. In the US, under an interim HHS policy announced on October 28, 2026 (published in the Federal Register on October 30), HHS does not intend to take enforcement action against state-licensed pharmacies that compound BPC-157 on its own for an individual prescription; that is non-enforcement, not FDA approval.
What is BPC-157 used for?
BPC-157 is referenced in recovery-oriented, regenerative medicine, and sports performance clinic contexts. Research is primarily preclinical and human evidence is limited.
Next step
Compare clinics offering this treatment
Use city pages, treatment comparisons, and clinic listings together. That gives you a better view of program quality, pricing context, and oversight than reading a guide in isolation.
Continue researching
Curated pricing and clinic research
Pricing comparisons
Treatment context
For clinics
Are you a clinic?
Get featured on this page and reach patients actively looking for peptide therapy, GLP-1 treatments, recovery support, and longevity care.